Common Human Struggles Are Increasingly Treated as Medical Conditions
March 29, 2026
No one wants to suffer. The drive to alleviate pain, both physical and emotional, is a fundamental human impulse and a cornerstone of modern medicine. But a quiet, profound shift is underway in how we define suffering itself. Experiences that were once considered difficult but normal parts of life—the deep sadness of grief, the anxieties of social life, the restlessness of childhood—are increasingly being framed as medical disorders that require a pharmaceutical solution. This trend, known as medicalization, is subtly redrawing the boundaries of what it means to be healthy, often with unintended and far-reaching consequences.
The evidence for this shift is compelling and can be seen in prescription data and diagnostic trends. For instance, the Diagnostic and Statistical Manual of Mental Disorders (DSM), the primary guide for psychiatric diagnoses in the United States, has expanded with each new edition. Its latest version, the DSM-5, controversially removed the “bereavement exclusion” for major depressive disorder. This meant that the profound sadness felt immediately after the death of a loved one could, after just two weeks, be diagnosed and treated as a clinical illness. Similarly, conditions like social anxiety disorder have seen diagnoses rise, blurring the line between clinical impairment and common shyness. In schools, behaviors once chalked up to youthful energy are now frequently assessed for Attention-Deficit/Hyperactivity Disorder (ADHD), leading to a significant increase in the prescription of stimulant medications for children.
Several powerful forces are driving this expansion of medical oversight into everyday life. One of the most significant is the influence of the pharmaceutical industry. In countries like the United States and New Zealand, direct-to-consumer advertising encourages people to see their problems through a medical lens. These ads often present relatable life struggles and then offer a branded medication as the simple, effective answer, prompting viewers to “ask your doctor.” This creates a patient-led demand for treatments for conditions they may not have previously considered medical issues.
Healthcare systems themselves also contribute to the problem. Primary care physicians are often under immense time pressure, with patient appointments lasting just 15 minutes. In that short window, it is far quicker and simpler to write a prescription than to engage in a lengthy conversation about a patient’s life circumstances, coping mechanisms, or non-medical solutions like therapy or lifestyle changes. This systemic reality can make a pill seem like the most efficient option for both the doctor and the patient seeking immediate relief.
Furthermore, our culture has developed a lower tolerance for discomfort. In a world that prizes productivity, happiness, and rapid solutions, the messy, slow, and often painful process of working through personal challenges can feel like a failure. Medicalization offers a seemingly scientific and definitive explanation for our struggles, transforming a personal failing into a manageable chemical imbalance. It removes the ambiguity and responsibility of navigating life’s inherent difficulties.
The consequences of this trend are more complex than just the risk of medication side effects. When we pathologize normal human emotions, we risk losing our ability to cope with them. Grief, for example, is a painful but essential process of adaptation to loss. By medicating it away, we may interfere with this natural emotional work. Labeling a shy person with a disorder can erode their self-confidence and discourage them from developing the social skills they need to overcome their discomfort. It can teach a generation that distress is not something to be understood and navigated, but an illness to be chemically suppressed.
This is not to say that medications for mental and emotional health are not vital. For individuals with severe, debilitating conditions like major depression, schizophrenia, or crippling anxiety, pharmacological treatments have been life-saving miracles. The danger lies in the indiscriminate application of medical labels to the milder end of the human emotional spectrum. The solution, therefore, is not to reject medical progress but to apply it with greater wisdom and restraint. This requires a cultural shift in how we view health. It means promoting a broader, more resilient definition of well-being that includes the capacity to endure and learn from hardship.
For healthcare providers, it may mean prioritizing longer consultation times and embracing approaches like “watchful waiting” before resorting to prescriptions. It means valuing and funding non-pharmacological interventions, such as psychotherapy, mindfulness, and community support programs. For individuals, it calls for a more critical engagement with our own health. It means asking whether our struggles are truly a sign of disease or a signal that something in our lives—our work, our relationships, our environment—needs to change. Modern medicine has given us powerful tools to fight disease, but its greatest challenge now may be learning to distinguish true illness from the ordinary, and often necessary, struggles of being human.